匹伐他汀调脂临床研究进展

被引：8

作者：

唐斌

阳国平

袁洪

黄志军

机构：

[1] 中南大学湘雅三医院心内科

来源：

中南药学 | 2008年 / 02期

关键词：

匹伐他汀; 临床研究; 调脂;

D O I：

暂无

中图分类号：

R541.4 [冠状动脉（粥样）硬化性心脏病（冠心病）];

学科分类号：

100201 [内科学];

摘要：

引用

收藏

页码：226 / 229

页数：4

相关论文

共 7 条

[1]

Functional interplay between the macrophage scavenger receptor class B type I and pitavastatin (NK-104) [J].

Han, JH ;

Parsons, M ;

Zhou, XY ;

Nicholson, AC ;

Gotto, AM ;

Hajjar, DP .

CIRCULATION, 2004, 110 (22) :3472-3479

[2]

Metabolic fate of pitavastatin, a new inhibitor of HMG-CoA reductase: human UDP-glucuronosyltransferase enzymes involved in lactonization [J].

Fujino, H ;

Yamada, I ;

Shimada, S ;

Yoneda, M ;

Kojima, J .

XENOBIOTICA, 2003, 33 (01) :27-41

[3]

Interaction between several medicines and statins [J].

Fujino, H ;

Saito, T ;

Tsunenari, Y ;

Kojima, J .

ARZNEIMITTEL-FORSCHUNG-DRUG RESEARCH, 2003, 53 (03) :145-153

[4]

Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial [J].

Shepherd, J ;

Blauw, GJ ;

Murphy, MB ;

Bollen, ELEM ;

Buckley, BM ;

Cobbe, SM ;

Ford, I ;

Gaw, A ;

Hyland, M ;

Jukema, JW ;

Kamper, AM ;

Macfarlane, PW ;

Meinders, AE ;

Norrie, J ;

Packard, CJ ;

Perry, IJ ;

Stott, DJ ;

Sweeney, BJ ;

Twomey, C ;

Westendorp, RGJ .

LANCET, 2002, 360 (9346) :1623-1630

[5]

A randomized, double-blind trial comparing the efficacy and safety of pitavastatin versus pravastatin in patients with primary hypercholesterolemia [J].

Saito, Y ;

Yamada, N ;

Teramoto, T ;

Itakura, H ;

Hata, Y ;

Nakaya, N ;

Mabuchi, H ;

Tushima, M ;

Sasaki, J ;

Ogawa, N ;

Goto, Y .

ATHEROSCLEROSIS, 2002, 162 (02) :373-379

[6]

Novel statins: Pharmacological and clinical results [J].

Bolego, C ;

Poli, A ;

Cignarella, A ;

Catapano, AL ;

Paoletti, R .

CARDIOVASCULAR DRUGS AND THERAPY, 2002, 16 (03) :251-257

[7]

NK-104: a novel synthetic HMG-CoA reductase inhibitor [J].

Kajinami, K ;

Mabuchi, H ;

Saito, Y .

EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2000, 9 (11) :2653-2661